The Green Organic Dutchman to use EnWave’s cannabis drying tech, share royalties with Tilray
TORONTO, January 3, 2019 -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has signed a royalty-bearing commercial sublicense (the “Agreement”) with EnWave Corporation (TSX-V:ENW) (“EnWave”) and Tilray, Inc. (NASDAQ:TLRY) (“Tilray”).
EnWave has developed Radiant Energy Vacuum (“REV™”) – an innovative, proprietary method for the precise dehydration of organic materials. EnWave has further developed patent-pending methods for uniformly drying and decontaminating cannabis through the use of REV™ technology, shortening the time from harvest to marketable cannabis products.
EnWave and Tilray entered into an exclusive partnership in October 2017 in which EnWave named Tilray as its licensed partner (the “License”). The License grants Tilray an exclusive right to use and sub-license EnWave’s proprietary REV™ dehydration technology in Canada. Under the terms of the License, EnWave and Tilray will share royalties from TGOD’s use of EnWave’s REV™ technology on an undisclosed basis
The Agreement grants TGOD the right to use EnWave’s proprietary Radiant Energy Vacuum (“REV™”) dehydration technology to dry organic cannabis in its Canadian operations. Pursuant to the Agreement, TGOD has signed an equipment purchase agreement and submitted a purchase order to EnWave for a large-scale 60kW commercial REV™ machine to initiate commercial production.
“We are incredibly excited to utilize this proprietary and advanced dehydration technology, which will promote consistency in the manufacturing of our premium organic products, improve space efficiency by reducing the need for drying rooms and quicken TGOD’s time from harvest to sale,” stated Brian Athaide, TGOD’s Chief Executive Officer.
On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.
ABOUT THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
The Green Organic Dutchman Holdings Ltd. is a premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America and the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kgs and is building 1,382,000 sq. ft. of cultivation facilities across Ontario, Quebec and Jamaica.
TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.